3Suppliers
5Customers
2Debt Items
12Related Chains

Source-Backed Evidence Depth

Mustang Bio, Inc. (MBIO) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

11Total relationships
2Distinct source URLs
3High confidence
0.760Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Mustang Bio, Inc. Suppliers

TickerNameConfidenceEvidence
FBIO Fortress Biotech, Inc. 72% Reciprocal relationship from FBIO graph: Reciprocal relationship from MBIO graph: Reciprocal relationship from FBIO graph: Zeneca plc as successor-in-interest to Alexion Pharmaceuticals, Inc. (“Astra…
FBIOP FBIOP 72% Reciprocal relationship from FBIOP graph: Reciprocal relationship from MBIO graph: Item 1. Business ​ OVERVIEW Mustang Bio, Inc. (“Mustang,” “we,” “us,” “our” or the “Company”) is a clinical-stage bi…
FBIOP FBIOP 72% Item 1. Business ​ OVERVIEW Mustang Bio, Inc. (“Mustang,” “we,” “us,” “our” or the “Company”) is a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs into p…

Mustang Bio, Inc. Customers

TickerNameConfidenceEvidence
FBIO Fortress Biotech, Inc. 72% Reciprocal relationship from FBIO graph: Reciprocal relationship from MBIO graph: Item 4. Mine Safety Disclosures 58 ​ ​ ​ Item 5. Other Information 59 ​ ​ ​ Item 6. Exhibits 59 ​ ​ ​ SIGNATURES 61 ​…
FBIO Fortress Biotech, Inc. 72% Item 4. Mine Safety Disclosures 58 ​ ​ ​ Item 5. Other Information 59 ​ ​ ​ Item 6. Exhibits 59 ​ ​ ​ SIGNATURES 61 ​ ​ ​ 2 Table of Contents SUMMARY OF RISK FACTORS ​ Our business is subject to risk…
FBIOP FBIOP 72% n, future events or otherwise . ​ Table of Contents SUMMARY OF RISK FACTORS ​ Our business is subject to risks of which you should be aware before making an investment decision. The risks described b…
FBIOP FBIOP 72% Reciprocal relationship from FBIOP graph: Reciprocal relationship from MBIO graph: n, future events or otherwise . ​ Table of Contents SUMMARY OF RISK FACTORS ​ Our business is subject to risks of wh…
OTHER-INDUSTRIES OTHER-INDUSTRIES 62% vectors in accordance with GMP, we will not be able to complete, or may be delayed in completing, the preclinical and clinical studies and manufacturing process validation activities required to supp…

Mustang Bio, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
MBIO-DEBT-10878 Warrants outstanding: 288184 90% xbrl warrant detail from xbrl 2026-03-31.
MBIO-DEBT-10879 Xbrl Convertible 90% xbrl convertible detail from xbrl 2023-12-31.

Mustang Bio, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Mustang Bio, Inc..

Mustang Bio, Inc. Ownership

HolderNameConfidenceEvidence
MBIO-OWNER-KESTRA-ADVISORY-SERVICES-LLC Kestra Advisory Services, LLC 90% 13F overlay lists Kestra Advisory Services, LLC as top holder; 22 tracked holders.

Mustang Bio, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
DERM Journey Medical Corporation 100.00 2
FBIOP Fortress Biotech, Inc. 100.00 1 ['customer', 'supplier']
OCSL Oaktree Specialty Lending Corporation 100.00 2
TGTX TG Therapeutics, Inc. 100.00 2
ERNA Ernexa Therapeutics Inc. 50.00 2
AZN AstraZeneca PLC 50.00 2
RDY Dr. Reddy's Laboratories Limited 50.00 2
FBIO Fortress Biotech, Inc. 38.88 1 ['customer', 'supplier']
ATXI Avenue Therapeutics, Inc. 14.78 2
XYF X Financial 14.78 2
LLY Eli Lilly and Company 14.78 2
AXSM Axsome Therapeutics, Inc. 14.78 2
🔐
MBIO
Unlock MBIO Supply Chain Data
Verified relationships include:
FBIOFortress Biotech, Inc.Supplier72%
FBIOPFBIOPSupplier72%
FBIOFortress Biotech, Inc.Customer72%
FBIOFortress Biotech, Inc.Customer72%
+7 more relationships locked
Subscribe — View plans →